ABEO Stock Summary and Trading Ideas (Abeona Therapeutics | NASDAQ:ABEO)

Abeona Therapeutics Inc is a clinical-stage biopharmaceutical company. The firm is focused on developing gene therapies and plasma-based products for life-threatening rare genetic diseases. Its clinical programs consist of pz-cel, an autologous, engineered cell therapy currently in development for recessive dystrophic epidermolysis bullosa (RDEB). The Company's development portfolio also features adeno-associated virus (AAV)-based gene therapies designed to treat unmet, medically needed ophthalmic diseases using the novel.

Abeona Therapeutics trades on the NASDAQ stock market under the symbol ABEO.

As of January 9, 2026, ABEO stock price climbed to $5.19 with 1,303,389 million shares trading.

ABEO has a beta of 1.10, meaning it tends to be more sensitive to market movements. ABEO has a correlation of 0.11 to the broad based SPY ETF.

ABEO has a market cap of $281.25 million. This is considered a Small Cap stock.

Last quarter Abeona Therapeutics reported $0 in Revenue and -$.10 earnings per share. This fell short of revenue expectation by $-5 million and exceeded earnings estimates by $.21.

In the last 3 years, ABEO traded as high as $9.01 and as low as $2.19.

The top ETF exchange traded funds that ABEO belongs to (by Net Assets): VTI, IWM, VXF, IWO, VTWO.

ABEO has underperformed the market in the last year with a price return of -12.9% while the SPY ETF gained +19.0%. ABEO has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -8.3% and -4.8%, respectively, while the SPY returned +3.7% and +0.5%, respectively.

ABEO support price is $4.94 and resistance is $5.24 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that ABEO shares will trade within this expected range on the day.